ACHE and depressive disorder: The variable clinical outcomes may reflect the fact that, by increasing synaptic levels of acetylcholine, AChE inhibitors increase stimulation of both muscarinic and nicotinic acetylcholine receptors, and these two receptors may be differentially involved in depression.